Assessment (domain) and specific measurement | Weeks 2–4 | Acute treatment phase | Follow-up phase | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4–11 weeks | 24 weeks | |||||||||||||||
End of session numbera | Taper | Follow up | ||||||||||||||
5 | 10 | 15 | 20 | [25] | [30] | 1 | 2 | 3 | 4 | 8 | 12 | 16 | 20 | 24 | ||
Consent | S* | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Screening | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Randomization | B* | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Baseline | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medical history | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Physical exam | S | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Laboratory measurements | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
SCID-I | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Current/past ATHF | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Lifetime drinking history | B | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
CAPS | B | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
THQ | B | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
LSC-R | B | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
BOMC | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medication use | S | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
rTMS treatment log | Â | x | x | x | x | x | x | Â | Â | Â | Â | Â | Â | Â | Â | Â |
rTMS taper log | Â | Â | Â | Â | Â | Â | Â | x | x | x | Â | Â | Â | Â | Â | Â |
HRSD and MADRS | Sb | x | x | x | x | x | x | Â | Â | Â | x | x | x | x | x | x |
BDI | B | x | x | x | x | x | x | Â | Â | Â | x | x | x | x | x | x |
QIDS-C16 | B | x | x | x | x | x | x | Â | Â | Â | x | x | x | x | x | x |
C-SSRS | S | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
C-SSRS follow up | Â | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
BSS | S | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
BHS | S | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
VR-36 | B | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
Neuropsychological battery | B | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
DAST | S | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
PCL | B | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
MAST | S | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | Â | Â | Â | Â | x |
STAXI-2 | S | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
Urine toxicology screen and alcohol test | S | Â | x | Â | x | Â | X | Â | x | Â | x | Â | x | Â | x | Â |
Protocol deviation | As required | |||||||||||||||
AE/SAE/UADE | As required |